WHO ICTRP trial
Evaluation of the effect of Lactobacillus reuteri probiotic in functional…
IRCT20150706023084N13 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20150706023084N13 |
|---|---|
| Public title | Evaluation of the effect of Lactobacillus reuteri probiotic in functional constipation |
| Scientific title | Evaluation of the effectiveness of Lactobacillus reuteri probiotic versus placebo in the treatment of functional constipation in children 3 to 18 years old |
| Primary sponsor | Faradaro Fanavar Mehr Company |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of);Iran (Islamic Republic of) |
| Conditions | functional constipation in children. Constipation;K59.0 |
| Interventions | Intervention 1: Intervention group: includes 80 patients who are diagnosed with functional constipation by a pediatric gastroenterologist for 28 days of probiotic Lactobacillus reuteri produced by Farabiotic Company(one sachet daily) plus… |
| Registration date | Dec 29, 2021 |
| Target size | 160 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: